This inventor holds 1 USPTO granted patent. Top assignee: University of Kentucky Research Foundation. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Innovations of John D Conklin, Jr.
Introduction
John D Conklin, Jr. is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs that enhance the delivery of nonsteroidal and steroidal agents. His work is characterized by a focus on creating permeable and non-irritating drug formulations.
Latest Patents
Conklin holds a patent for "Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents." This patent describes prodrugs that contain an active drug molecule linked to a polyethylene glycol group. The exemplary soluble ester prodrugs include well-known compounds such as naproxen, triamcinolone acetonide, gancyclovir, taxol, cyclosporin, dideoxyinosine, trihydroxy steroids, and flurbiprofen molecules. The patent also outlines pharmaceutical compositions containing these prodrugs and methods for using these esters to treat various disease states or symptoms. He has 1 patent to his name.
Career Highlights
John D Conklin, Jr. is affiliated with the University of Kentucky Research Foundation, where he continues to advance his research in drug development. His innovative approach to prodrugs has the potential to improve therapeutic outcomes for patients.
Collaborations
Throughout his career, Conklin has collaborated with esteemed colleagues such as Paul Ashton and Peter G Glavinos. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
John D Conklin, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His work on prodrugs represents a significant advancement in drug delivery systems, showcasing the importance of research and collaboration in the field.